Evolutive Models, Algorithms and Predictive Parameters for the Progression of Hepatic Steatosis
-
Published:2024-04-03
Issue:4
Volume:14
Page:198
-
ISSN:2218-1989
-
Container-title:Metabolites
-
language:en
-
Short-container-title:Metabolites
Author:
Tudor Marinela Sînziana1, Gheorman Veronica2ORCID, Simeanu Georgiana-Mihaela1, Dobrinescu Adrian3, Pădureanu Vlad2ORCID, Dinescu Venera Cristina4, Forțofoiu Mircea-Cătălin5ORCID
Affiliation:
1. Doctoral School, University of Medicine and Pharmacy of Craiova, Petru Rareș 2 Str, 200349 Craiova, Romania 2. Department 3 Medical Semiology, University of Medicine and Pharmacy of Craiova, Petru Rareș 2 Str, 200349 Craiova, Romania 3. Department of Thoracic Surgery, University of Medicine and Pharmacy of Craiova, Petru Rareș 2 Str, 200349 Craiova, Romania 4. Department of Health Promotion and Occupational Medicine, University of Medicine and Pharmacy of Craiova, Petru Rareș 2 Str, 200349 Craiova, Romania 5. Department 3 Medical Semiology, University of Medicine and Pharmacy of Craiova, Clinical Municipal Hospital “Philanthropy” of Craiova, 200143 Craiova, Romania
Abstract
The utilization of evolutive models and algorithms for predicting the evolution of hepatic steatosis holds immense potential benefits. These computational approaches enable the analysis of complex datasets, capturing temporal dynamics and providing personalized prognostic insights. By optimizing intervention planning and identifying critical transition points, they promise to revolutionize our approach to understanding and managing hepatic steatosis progression, ultimately leading to enhanced patient care and outcomes in clinical settings. This paradigm shift towards a more dynamic, personalized, and comprehensive approach to hepatic steatosis progression signifies a significant advancement in healthcare. The application of evolutive models and algorithms allows for a nuanced characterization of disease trajectories, facilitating tailored interventions and optimizing clinical decision-making. Furthermore, these computational tools offer a framework for integrating diverse data sources, creating a more holistic understanding of hepatic steatosis progression. In summary, the potential benefits encompass the ability to analyze complex datasets, capture temporal dynamics, provide personalized prognostic insights, optimize intervention planning, identify critical transition points, and integrate diverse data sources. The application of evolutive models and algorithms has the potential to revolutionize our understanding and management of hepatic steatosis, ultimately leading to improved patient outcomes in clinical settings.
Reference53 articles.
1. Pouwels, S., Sakran, N., Graham, Y., Leal, A., Pintar, T., Yang, W., Kassir, R., Singhal, R., Mahawar, K., and Ramnarain, D. (2022). Non-alcoholic fatty liver disease (NAFLD): A review of pathophysiology, clinical management and effects of weight loss. BMC Endocr. Disord., 22. 2. Antunes, C., Azadfard, M., Hoilat, G.J., and Gupta, M. (2024). StatPearls [Internet], StatPearls Publishing. 3. Berardo, C., Di Pasqua, L.G., Cagna, M., Richelmi, P., Vairetti, M., and Ferrigno, A. (2020). Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research. Int. J. Mol. Sci., 21. 4. Malnick, S.D.H., Alin, P., Somin, M., and Neuman, M.G. (2022). Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different. Int. J. Mol. Sci., 23. 5. NAFLD as a continuum: From obesity to metabolic syndrome and diabetes;Valerio;Diabetol. Metab. Syndr.,2020
|
|